Atlas Trials

Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV

Clinical trial NCT07390474 · RECRUITING

Trial details

NCT number
NCT07390474
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
HIV
Start date
2026-03-25
Primary completion
2027-12-14
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.